Harvard Bioscience
HBIO
HBIO
61 hedge funds and large institutions have $54.2M invested in Harvard Bioscience in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
61
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.11M | |
| 2 | +$938K | |
| 3 | +$752K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$488K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$306K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$1.28M | |
| 3 | -$1.13M | |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$177K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$160K |